Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Financial aid nonprofits merge to do more for patients feeling pinched by medical bills on top of overall inflation
Two medical charities that last year gave $640 million to 200,000 struggling Americans are combining forces so they can expand their collective wherewithal.
Cardiologist surrenders medical license after faking penile cancer diagnosis
An interventional cardiologist has lost his ability to practice in multiple states after faking a cancer diagnosis, lying about his training and allegedly asking a colleague to falsify documents.
Radiology societies fight Medicare Administrative Contractor’s proposed coverage restriction
National Government Services is seeking to limit the use of thermal destruction of the intraosseous basivertebral nerve, aka the Intracept procedure, drawing ire from ACR and SIR.
RadNet has allocated over $340M to acquisitions already in 2026. Leaders discuss why and what’s next
The Los Angeles-based imaging center operator recently reached a deal to acquire AI firm Gleamer for $270 million, on top of spending $74 million to add over a dozen imaging centers.
Company seeks to become a ‘leader in interventional radiology’ with recent acquisition
Quantum Surgical, which specializes in minimally invasive, robotic-assisted cancer care, recently reached a deal to acquire NeuWave Medical, previously held by J&J.

Financial aid nonprofits merge to do more for patients feeling pinched by medical bills on top of overall inflation

Two medical charities that last year gave $640 million to 200,000 struggling Americans are combining forces so they can expand their collective wherewithal.

artificial intelligence AI in healthcare

Cardiologist surrenders medical license after faking penile cancer diagnosis

An interventional cardiologist has lost his ability to practice in multiple states after faking a cancer diagnosis, lying about his training and allegedly asking a colleague to falsify documents.

Radiology societies fight Medicare Administrative Contractor’s proposed coverage restriction

National Government Services is seeking to limit the use of thermal destruction of the intraosseous basivertebral nerve, aka the Intracept procedure, drawing ire from ACR and SIR.

RadNet has allocated over $340M to acquisitions already in 2026. Leaders discuss why and what’s next

The Los Angeles-based imaging center operator recently reached a deal to acquire AI firm Gleamer for $270 million, on top of spending $74 million to add over a dozen imaging centers.

mergers and acquisitions M&A consolidation puzzle business deal

Company seeks to become a ‘leader in interventional radiology’ with recent acquisition

Quantum Surgical, which specializes in minimally invasive, robotic-assisted cancer care, recently reached a deal to acquire NeuWave Medical, previously held by J&J.

Strategic Radiology expands into new state, adding Kentucky private practice

The coalition of independent imaging groups on March 3 announced the addition Central Kentucky Radiology PLLC and its 14 physicians.

Cyberattack on healthcare RCM vendor may have impacted 140K patients

The details stem from a report from SecurityWeek, but they’re a little fuzzy. After a 12 GB data trove was posted to the dark web, Vikor Scientific reported to HHS that there were nearly 140,000 victims. However, the source of the breach may be a third-party revenue cycle company, Catalyst RCM.

artificial intelligence AI policy washington capitol

HHS tells employees to abandon Claude AI, as Trump feuds with developer Anthropic

The outlet NOTUS was the first to break the news, citing an internal email it obtained written by government officials. Agencies under the Department of Health and Human Services have been told to seek alternatives, mainly ChatGPT or Gemini. The shift could throw a wrench in the FDA’s plans to use Claude for speedy drug approvals.